| Identifier Type | Value |
|---|
| HGNC ID | HGNC:2928 |
| Approved Symbol | DMD |
| Approved Name | dystrophin |
| Ensembl Gene ID | ENSG00000198947 |
| NCBI Entrez Gene ID | 1756 |
| OMIM Gene ID | 300377 |
| Locus Type | protein-coding gene |
| Status | Approved |
Genomic Location
| Attribute | Value |
|---|
| Chromosome | X |
| Cytogenetic Band | Xp21.2-p21.1 |
| Start Position (GRCh38) | 31,097,677 |
| End Position (GRCh38) | 33,339,609 |
| Strand | Minus (-) |
| Gene Length | 2,241,932 bp (~2.2 Mb) |
Gene Aliases & Previous Symbols
- Aliases: BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272
- Previous Symbol: MRX85
- Gene Groups: Zinc fingers ZZ-type, MicroRNA protein coding host genes, Spectrin repeat containing
Section 2: Transcript Identifiers
Summary
| Metric | Count |
|---|
| Total Ensembl Transcripts | 91 |
| Protein-coding | 35 |
| Retained intron | 32 |
| Nonsense-mediated decay | 4 |
| Protein-coding CDS not defined | 18 |
Ensembl Transcripts (Protein-coding - Top 30)
| Transcript ID | Biotype | Start | End |
|---|
| ENST00000357033 ⭐ | protein_coding | 31,119,222 | 33,211,549 |
| ENST00000288447 | protein_coding | 32,516,596 | 33,339,609 |
| ENST00000343523 | protein_coding | 31,119,228 | 31,508,481 |
| ENST00000358062 | protein_coding | 31,119,221 | 32,362,958 |
| ENST00000359836 | protein_coding | 31,119,228 | 32,155,469 |
| ENST00000361471 | protein_coding | 31,121,556 | 31,266,907 |
| ENST00000378677 | protein_coding | 31,119,228 | 33,128,360 |
| ENST00000378680 | protein_coding | 31,121,673 | 31,266,949 |
| ENST00000378702 | protein_coding | 31,121,184 | 31,266,857 |
| ENST00000378705 | protein_coding | 31,169,586 | 31,206,600 |
| ENST00000378707 | protein_coding | 31,119,228 | 32,155,469 |
| ENST00000378723 | protein_coding | 31,119,219 | 31,266,952 |
| ENST00000420596 | protein_coding | 32,364,681 | 33,211,312 |
| ENST00000447523 | protein_coding | 32,573,611 | 32,849,802 |
| ENST00000448370 | protein_coding | 32,364,681 | 33,211,312 |
| ENST00000474231 | protein_coding | 31,121,397 | 32,155,469 |
| ENST00000493412 | protein_coding | 32,342,631 | 32,348,510 |
| ENST00000541735 | protein_coding | 31,119,228 | 32,155,469 |
| ENST00000619831 | protein_coding | 31,119,222 | 32,412,237 |
| ENST00000620040 | protein_coding | 31,119,398 | 32,155,469 |
RefSeq Transcripts (Human)
| Accession | Type | Status | MANE Select |
|---|
| NM_004006 ⭐ | mRNA | REVIEWED | Yes |
| NM_000109 | mRNA | REVIEWED | No |
| NM_004009 | mRNA | REVIEWED | No |
| NM_004010 | mRNA | REVIEWED | No |
| NM_004011 | mRNA | REVIEWED | No |
| NM_004012 | mRNA | REVIEWED | No |
| NM_004013 | mRNA | REVIEWED | No |
| NM_004014 | mRNA | REVIEWED | No |
| NM_004015 | mRNA | REVIEWED | No |
| NM_004016 | mRNA | REVIEWED | No |
| NM_004017 | mRNA | REVIEWED | No |
| NM_004018 | mRNA | REVIEWED | No |
| NM_004019 | mRNA | REVIEWED | No |
| NM_004020 | mRNA | REVIEWED | No |
| NM_004021 | mRNA | REVIEWED | No |
| NM_004022 | mRNA | REVIEWED | No |
| NM_004023 | mRNA | REVIEWED | No |
CCDS IDs (Total: 11)
CCDS14229, CCDS14230, CCDS14231, CCDS14232, CCDS14233, CCDS14234, CCDS48091, CCDS55394, CCDS55395, CCDS94585, CCDS94586
Canonical Transcript Exons (ENST00000357033)
Total Exon Count: 79
| Exon ID | Start | End | Strand |
|---|
| ENSE00001899141 | 33,211,282 | 33,211,549 | - |
| ENSE00003463064 | 33,020,139 | 33,020,200 | - |
| ENSE00001640206 | 32,844,783 | 32,844,860 | - |
| ENSE00001691097 | 32,849,728 | 32,849,820 | - |
| ENSE00001685282 | 32,823,295 | 32,823,387 | - |
| ENSE00001789498 | 32,816,468 | 32,816,640 | - |
| ENSE00001434995 | 32,697,870 | 32,697,998 | - |
| ENSE00001436506 | 32,699,112 | 32,699,293 | - |
| ENSE00001435581 | 32,644,964 | 32,645,152 | - |
| ENSE00001435687 | 32,644,132 | 32,644,313 | - |
| ... | ... | ... | ... |
| ENSE00003901420 | 31,119,222 | 31,121,930 | - |
(Full list of 79 exons available)
Section 3: Protein Identifiers
UniProt Accessions
| Accession | Name | Status | Length | Mass |
|---|
| P11532 ⭐ | Dystrophin | Reviewed (Swiss-Prot) | 3,685 aa | 426,778 Da |
RefSeq Protein Accessions (Human)
| Accession | Status | MANE Select |
|---|
| NP_003997 ⭐ | REVIEWED | Yes |
| NP_000100 | REVIEWED | No |
| NP_004000 | REVIEWED | No |
| NP_004001 | REVIEWED | No |
| NP_004002 | REVIEWED | No |
| NP_004003 | REVIEWED | No |
| NP_004004 | REVIEWED | No |
| NP_004005 | REVIEWED | No |
| NP_004006 | REVIEWED | No |
| NP_004007 | REVIEWED | No |
| NP_004008 | REVIEWED | No |
| NP_004009 | REVIEWED | No |
| NP_004010 | REVIEWED | No |
| NP_004011 | REVIEWED | No |
| NP_004012 | REVIEWED | No |
| NP_004013 | REVIEWED | No |
| NP_004014 | REVIEWED | No |
Protein Domains and Families (Total: 14)
| Domain/Family ID | Name | Type |
|---|
| IPR001715 | CH_dom | Domain |
| IPR002017 | Spectrin_repeat | Repeat |
| IPR018159 | Spectrin/alpha-actinin | Repeat |
| IPR000433 | Znf_ZZ | Domain |
| IPR001202 | WW_dom | Domain |
| IPR015153 | EF-hand_dom_typ1 | Domain |
| IPR015154 | EF-hand_dom_typ2 | Domain |
| IPR001589 | Actinin_actin-bd_CS | Conserved_site |
| IPR035436 | Dystrophin/utrophin | Family |
| IPR050774 | KCMF1/Dystrophin | Family |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR036020 | WW_dom_sf | Homologous_superfamily |
| IPR036872 | CH_dom_sf | Homologous_superfamily |
| IPR043145 | Znf_ZZ_sf | Homologous_superfamily |
Section 4: Structure Identifiers
Experimental Structures (Total: 5 PDB entries)
| PDB ID | Title | Method | Resolution |
|---|
| 9D58 | Human Dystrophin tandem calponin homology actin-binding domain crystallized in a closed-state conformation | X-RAY DIFFRACTION | 1.94 Å |
| 1EG3 | Structure of a dystrophin WW domain fragment in complex with a beta-dystroglycan peptide | X-RAY DIFFRACTION | 2.0 Å |
| 1EG4 | Structure of a dystrophin WW domain fragment in complex with a beta-dystroglycan peptide | X-RAY DIFFRACTION | 2.0 Å |
| 3UUN | Crystal Structure of N-terminal first spectrin repeat of dystrophin | X-RAY DIFFRACTION | 2.3 Å |
| 1DXX | N-terminal Actin-binding Domain of Human Dystrophin | X-RAY DIFFRACTION | 2.6 Å |
Predicted Structures
| Source | Model ID | Coverage |
|---|
| AlphaFold | AF-P11532-F1 | Full-length predicted |
| Swiss-Model | Available | Partial coverage |
Section 5: Cross-Species Orthologs
Orthologs in Model Organisms
| Organism | Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000045103 | Dmd | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000046366 | Dmd | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000008487 | dmd | protein_coding |
| Fruit fly (D. melanogaster) | No direct ortholog | - | - |
| Worm (C. elegans) | No direct ortholog | - | - |
| Yeast (S. cerevisiae) | No ortholog | - | - |
Human Paralogs (Total: 36)
| Gene ID | Symbol | Description |
|---|
| ENSG00000152818 | UTRN | Utrophin (closest paralog) |
| ENSG00000102385 | DRP2 | Dystrophin related protein 2 |
| ENSG00000134769 | DTNA | Dystrobrevin alpha |
| ENSG00000138101 | DTNB | Dystrobrevin beta |
| ENSG00000232125 | DYTN | Dystrotelin |
| ENSG00000072110 | ACTN1 | Actinin alpha 1 |
| ENSG00000077522 | ACTN2 | Actinin alpha 2 |
| ENSG00000248746 | ACTN3 | Actinin alpha 3 |
| ENSG00000130402 | ACTN4 | Actinin alpha 4 |
| ENSG00000163554 | SPTA1 | Spectrin alpha |
| ENSG00000070182 | SPTB | Spectrin beta |
| ENSG00000115306 | SPTBN1 | Spectrin beta 1 |
| ENSG00000173898 | SPTBN2 | Spectrin beta 2 |
| ENSG00000160460 | SPTBN4 | Spectrin beta 4 |
| ENSG00000137877 | SPTBN5 | Spectrin beta 5 |
| ENSG00000197694 | SPTAN1 | Spectrin alpha 1 |
| ENSG00000196924 | FLNA | Filamin A |
| ENSG00000136068 | FLNB | Filamin B |
| ENSG00000128591 | FLNC | Filamin C |
| ENSG00000127603 | MACF1 | Microtubule-actin crosslinking factor 1 |
Section 6: Clinical Variants & AI Predictions
ClinVar Summary
| Classification | Count |
|---|
| Total Variants | 11,261 |
| Pathogenic | 2,500+ |
| Likely Pathogenic | 800+ |
| Uncertain Significance (VUS) | 5,000+ |
| Likely Benign | 1,000+ |
| Benign | 500+ |
| Conflicting Classifications | 500+ |
TOP 50 Pathogenic Variants
| ClinVar ID | HGVS Notation | Type | Classification |
|---|
| 1066543 | NM_004006.3(DMD):c.961-2A>G | SNV | Pathogenic |
| 1068684 | NM_004006.3(DMD):c.1402_1406del (p.Glu468fs) | Deletion | Pathogenic |
| 1069390 | NM_004006.3(DMD):c.3426C>A (p.Cys1142Ter) | SNV | Pathogenic |
| 1069704 | NM_004006.3(DMD):c.418del (p.Leu140fs) | Deletion | Pathogenic |
| 1069818 | NM_004006.3(DMD):c.1383dup (p.Asp462Ter) | Duplication | Pathogenic |
| 1069895 | NM_004006.3(DMD):c.5404C>T (p.Gln1802Ter) | SNV | Pathogenic |
| 1069896 | NM_004006.3(DMD):c.4777G>T (p.Glu1593Ter) | SNV | Pathogenic |
| 1069989 | NM_004006.3(DMD):c.8853_8865del (p.Gln2952fs) | Deletion | Pathogenic |
| 1070053 | NM_004006.3(DMD):c.3511G>T (p.Glu1171Ter) | SNV | Pathogenic |
| 1070054 | NM_004006.3(DMD):c.2994T>A (p.Tyr998Ter) | SNV | Pathogenic |
| 1070319 | NM_004006.3(DMD):c.31+1G>A | SNV | Pathogenic |
| 1070660 | NM_004006.3(DMD):c.2508_2509dup (p.Asn837fs) | Microsatellite | Pathogenic |
| 1070671 | NM_004006.3(DMD):c.1696G>T (p.Glu566Ter) | SNV | Pathogenic |
| 1071032 | NM_004006.3(DMD):c.568C>T (p.Gln190Ter) | SNV | Pathogenic |
| 1071092 | NM_004006.3(DMD):c.1240G>T (p.Glu414Ter) | SNV | Pathogenic |
| 1071406 | NM_004006.3(DMD):c.3088A>T (p.Lys1030Ter) | SNV | Pathogenic |
| 1071448 | NM_004006.3(DMD):c.1150-2_1150-1del | Deletion | Pathogenic |
| 1071576 | NM_004006.3(DMD):c.4518+2T>G | SNV | Pathogenic |
| 1071817 | NM_004006.3(DMD):c.142dup (p.Arg48fs) | Duplication | Pathogenic |
| 1071899 | NM_004006.3(DMD):c.8745G>A (p.Trp2915Ter) | SNV | Pathogenic |
| 1071900 | NM_004006.3(DMD):c.8491C>T (p.Gln2831Ter) | SNV | Pathogenic |
| 1071901 | NM_004006.3(DMD):c.8416C>T (p.Gln2806Ter) | SNV | Pathogenic |
| 1071902 | NM_004006.3(DMD):c.4864G>T (p.Glu1622Ter) | SNV | Pathogenic |
| 1071903 | NM_004006.3(DMD):c.7822G>T (p.Glu2608Ter) | SNV | Pathogenic |
| 1072046 | NM_004006.3(DMD):c.6677G>A (p.Trp2226Ter) | SNV | Pathogenic |
| 1072120 | NM_004006.3(DMD):c.2803+5_2803+8del | Microsatellite | Pathogenic |
| 1072121 | NM_004006.3(DMD):c.2605C>T (p.Gln869Ter) | SNV | Pathogenic |
| 1072122 | NM_004006.3(DMD):c.2521C>T (p.Gln841Ter) | SNV | Pathogenic |
| 1072123 | NM_004006.3(DMD):c.2353C>T (p.Gln785Ter) | SNV | Pathogenic |
| 1072167 | NM_004006.3(DMD):c.94-2A>C | SNV | Pathogenic |
| 1072276 | NM_004006.3(DMD):c.1603-2A>T | SNV | Pathogenic |
| 1072763 | NM_004006.3(DMD):c.6254G>A (p.Trp2085Ter) | SNV | Pathogenic |
| 1072774 | NM_004006.3(DMD):c.10642dup (p.Thr3548fs) | Duplication | Pathogenic |
| 1072778 | NM_004006.3(DMD):c.6913-2A>C | SNV | Pathogenic |
| 1072908 | NM_004006.3(DMD):c.9415A>T (p.Lys3139Ter) | SNV | Pathogenic |
| 1072951 | NM_004006.3(DMD):c.9624del (p.Ala3209fs) | Deletion | Pathogenic |
| 1073002 | NM_004006.3(DMD):c.2695G>T (p.Glu899Ter) | SNV | Pathogenic |
| 1073022 | NM_004006.3(DMD):c.7449del (p.Asp2484fs) | Deletion | Pathogenic |
| 1073030 | NM_004006.3(DMD):c.790G>T (p.Glu264Ter) | SNV | Pathogenic |
| 1073408 | NM_004006.3(DMD):c.2917G>T (p.Glu973Ter) | SNV | Pathogenic |
| 1073643 | NM_004006.3(DMD):c.10224dup (p.Pro3409fs) | Duplication | Pathogenic |
| 1073681 | NM_004006.3(DMD):c.1983dup (p.Thr662fs) | Duplication | Pathogenic |
| 1073692 | NM_004006.3(DMD):c.2760_2761del (p.Gln920fs) | Deletion | Pathogenic |
| 1073735 | NM_004006.3(DMD):c.6604del (p.Arg2202fs) | Deletion | Pathogenic |
| 1073854 | NM_004006.3(DMD):c.3727_3728del (p.Leu1243fs) | Microsatellite | Pathogenic |
| 1074008 | NM_004006.3(DMD):c.1961T>A (p.Leu654Ter) | SNV | Pathogenic |
| 1074009 | NM_004006.3(DMD):c.1339A>T (p.Arg447Ter) | SNV | Pathogenic |
| 1074010 | NM_004006.3(DMD):c.1721G>A (p.Trp574Ter) | SNV | Pathogenic |
SpliceAI Predictions
Total Predictions: 7,041
| TOP 50 High-Impact Splice Variants (Score ≥0.8) |
|---|
| Variant ID |
| ------------ |
| X:31146284:CACTT:C |
| X:31146285:ACTT:A |
| X:31146286:CTTA:C |
| X:31146287:TTA:T |
| X:31146288:TA:T |
| X:31146289:A:AC |
| X:31146289:ACC:A |
| X:31146290:C:CC |
| X:31146425:C:CT |
| X:31134095:AGCTT:A |
| X:31134096:GCTT:G |
| X:31134097:CTTA:C |
| X:31134098:TTA:T |
| X:31134099:TACCT:T |
| X:31146289:ACCCA:A |
| X:31146413:GG:G |
| X:31146414:GC:G |
| X:31146415:C:CA |
| X:31146416:T:C |
| X:31146421:C:CT |
| X:31146426:A:T |
| X:31147262:T:C |
| X:31134192:CAC:C |
| X:31134196:T:C |
| X:31134199:A:AC |
| X:31133681:C:CT |
| X:31133682:T:TT |
| X:31130704:TA:T |
| X:31130705:AA:A |
| X:31134891:C:CT |
| X:31146352:CCT:C |
| X:31146354:TCT:T |
| X:31146410:TGGGG:T |
| X:31146411:GGGG:G |
| X:31146412:GGG:G |
| X:31134191:TCACC:T |
| X:31134192:CACCT:C |
| X:31121931:C:CC |
| X:31126709:A:T |
| X:31121928:GTCC:G |
| X:31121929:TCC:T |
| X:31121930:CCT:C |
| X:31121931:C:T |
| X:31121932:T:G |
| X:31147258:C:A |
| X:31134195:C:CC |
| X:31136416:C:CT |
| X:31146353:CTC:C |
| X:31134206:C:CT |
AlphaMissense Predictions
Total Predictions: 24,447
| TOP 50 Likely Pathogenic Missense Variants |
|---|
| Variant |
| --------- |
| X:31147294:A:G |
| X:31147285:A:G |
| X:31147282:A:G |
| X:31147290:C:A |
| X:31147290:C:G |
| X:31147296:C:A |
| X:31147296:C:G |
| X:31147294:A:C |
| X:31147291:C:A |
| X:31147291:C:G |
| X:31147297:C:A |
| X:31147297:C:G |
| X:31147298:T:C |
| X:31147285:A:T |
| X:31147282:A:C |
| X:31134115:G:C |
| X:31134115:G:T |
| X:31147288:T:G |
| X:31147285:A:C |
| X:31147282:A:T |
| X:31147292:T:C |
| X:31147294:A:T |
| X:31147295:G:C |
| X:31134128:A:G |
| X:31134128:A:T |
| X:31147298:T:A |
| X:31147292:T:A |
| X:31147300:T:G |
| X:31134116:A:G |
| X:31134116:A:C |
| X:31147295:G:T |
| X:31134128:A:C |
| X:31146310:A:C |
| X:31146413:G:A |
| X:31147297:C:T |
| X:31147283:G:T |
| X:31147283:G:C |
| X:31134141:C:A |
| X:31134129:G:A |
| X:31134140:A:T |
| X:31134117:A:C |
| X:31134131:T:G |
| X:31134117:A:T |
| X:31147291:C:T |
| X:31146391:A:C |
| X:31134137:A:T |
| X:31146413:G:T |
| X:31147286:G:C |
| X:31134137:A:C |
| X:31146390:C:G |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways (Total: 3)
| Pathway ID | Pathway Name |
|---|
| R-HSA-390522 | Striated Muscle Contraction |
| R-HSA-3000171 | Non-integrin membrane-ECM interactions |
| R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) |
Gene Ontology Annotations (Total: 51)
Molecular Function (Count: 9)
| GO ID | Term |
|---|
| GO:0003779 | actin binding |
| GO:0002162 | dystroglycan binding |
| GO:0017022 | myosin binding |
| GO:0017166 | vinculin binding |
| GO:0050998 | nitric-oxide synthase binding |
| GO:0008270 | zinc ion binding |
| GO:0005200 | structural constituent of cytoskeleton |
| GO:0008307 | structural constituent of muscle |
Biological Process (Count: 27)
| GO ID | Term |
|---|
| GO:0007517 | muscle organ development |
| GO:0007519 | skeletal muscle tissue development |
| GO:0055001 | muscle cell development |
| GO:0060048 | cardiac muscle contraction |
| GO:0014819 | regulation of skeletal muscle contraction |
| GO:0090257 | regulation of muscle system process |
| GO:0046716 | muscle cell cellular homeostasis |
| GO:0035994 | response to muscle stretch |
| GO:0002027 | regulation of heart rate |
| GO:0086001 | cardiac muscle cell action potential |
| GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion |
| GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
| GO:1903169 | regulation of calcium ion transmembrane transport |
| GO:1902305 | regulation of sodium ion transmembrane transport |
| GO:0035633 | maintenance of blood-brain barrier |
| GO:0048666 | neuron development |
| GO:0010976 | positive regulation of neuron projection development |
| GO:0045666 | positive regulation of neuron differentiation |
| GO:0099536 | synaptic signaling |
Cellular Component (Count: 15)
| GO ID | Term |
|---|
| GO:0016010 | dystrophin-associated glycoprotein complex |
| GO:0016013 | syntrophin complex |
| GO:0042383 | sarcolemma |
| GO:0043034 | costamere |
| GO:0030018 | Z disc |
| GO:0005886 | plasma membrane |
| GO:0009986 | cell surface |
| GO:0045211 | postsynaptic membrane |
| GO:0045202 | synapse |
| GO:0005856 | cytoskeleton |
| GO:0002385 | muscle tissue |
| GO:0045121 | membrane raft |
| GO:0030055 | cell-substrate junction |
| GO:0005634 | nucleus |
| GO:0005829 | cytosol |
Section 8: Protein Interactions & Molecular Networks
Protein-Protein Interaction Summary
| Database | Interaction Count |
|---|
| STRING | 2,170+ |
| BioGRID | 175+ |
| IntAct | 131+ |
TOP 50 STRING Interactions (Highest Confidence)
| Interacting Protein | UniProt | Score |
|---|
| DAG1 (Dystroglycan) | Q14118 | 999 |
| DMD (self-interaction) | P11532 | 999 |
| DTNA (Dystrobrevin alpha) | Q14714 | 996 |
| DTNB (Dystrobrevin beta) | Q13326 | 965 |
| SNTA1 (Syntrophin alpha-1) | Q13424 | 966 |
| SNTB1 (Syntrophin beta-1) | Q92629 | 965 |
| SNTB2 (Syntrophin beta-2) | Q13884 | 956 |
| SGCA (Sarcoglycan alpha) | Q16586 | 982 |
| SGCB (Sarcoglycan beta) | Q16585 | 923 |
| SGCG (Sarcoglycan gamma) | Q13326 | 965 |
| SGCD (Sarcoglycan delta) | Q92629 | 965 |
| UTRN (Utrophin) | P46939 | 972 |
| NOS1 (Nitric oxide synthase 1) | P29475 | 895 |
| VCL (Vinculin) | P18206 | 933 |
| ACTN2 (Actinin alpha-2) | P35609 | 965 |
| DES (Desmin) | P17661 | 830 |
| LAMA2 (Laminin alpha-2) | P24043 | 957 |
| CAV3 (Caveolin-3) | P56539 | 901 |
| PLEC (Plectin) | Q15149 | 897 |
| TTN (Titin) | Q8WZ42 | 849 |
TOP 50 IntAct Interactions
| Interaction ID | Interactor A | Interactor B | Type | Confidence |
|---|
| EBI-10187548 | DMD | DTNB | physical association | 0.890 |
| EBI-10319402 | CTNNAL1 | DMD | physical association | 0.880 |
| EBI-295853 | SNTB1 | DMD | physical association | 0.840 |
| EBI-30875745 | DMD | SNTA1 | physical association | 0.800 |
| EBI-10283592 | DMD | HAUS1 | physical association | 0.800 |
| EBI-30875791 | DMD | DTNA | physical association | 0.760 |
| EBI-368283 | SNTB2 | DMD | physical association | 0.740 |
| EBI-12702602 | HNF4A | DMD | physical association | 0.560 |
| EBI-21273895 | ADRA1D | DMD | association | 0.530 |
| EBI-54452660 | DMD | RUNX2 | direct interaction | 0.440 |
Protein Similarity (ESM2 Embedding - Total: 64)
| UniProt | Similarity | Avg Similarity |
|---|
| Q9UPN3 (MACF1) | 0.9999 | 0.9900 |
| Q9QXZ0 (Utrophin, mouse) | 0.9999 | 0.9898 |
| Q91ZU6 | 0.9996 | 0.9890 |
| Q8NF91 (Nesprin-1) | 0.9997 | 0.9890 |
| Q6ZWR6 (Nesprin-2) | 0.9997 | 0.9890 |
| P11533 (Dystrophin, rat) | 0.9990 | 0.9890 |
| P46939 (UTRN) | 0.9990 | 0.9886 |
| P11531 (Dystrophin, mouse) | 0.9999 | 0.9887 |
| P11530 (Dystrophin, rabbit) | 0.9999 | 0.9886 |
| G3V7L1 | 0.9990 | 0.9883 |
Sequence Homology (DIAMOND - Total: 122+)
| UniProt | Identity | Bitscore | Description |
|---|
| Q03001 (MACF1/ACF7) | 77.6% | 10067 | Microtubule-actin crosslinking factor |
| Q8NF91 (SYNE1) | 84.1% | 13873 | Nesprin-1 |
| Q6ZWR6 (SYNE2) | 84.1% | 13865 | Nesprin-2 |
| O97592 (DMD, bovine) | 94.6% | 6542 | Dystrophin |
| P11530 (DMD, rabbit) | 96.2% | 6642 | Dystrophin |
| P11531 (DMD, mouse) | 96.2% | 6636 | Dystrophin |
| D3ZHV2 (DMD, rat) | 97.5% | 6420 | Dystrophin |
| Q5GN48 (DMD, canine) | 94.6% | 6546 | Dystrophin |
| P11533 (UTRN, human) | 77.7% | 5413 | Utrophin |
| Q15149 (PLEC) | 91.8% | 4957 | Plectin |
Section 9: Transcription Factor Regulatory Data
Note: DMD does NOT encode a transcription factor. It encodes a structural protein (dystrophin).
Upstream Transcriptional Regulators of DMD (CollecTRI)
| TF Gene | Regulation | Confidence |
|---|
| MYOD1 | Activation | High |
| SP1 | Activation | High |
| SP3 | Activation | High |
| SRF | Unknown | High |
| TFAP2A | Unknown | High |
| YY1 | Unknown | High |
| HR | Unknown | Low |
Downstream Targets
Not applicable - DMD is not a transcription factor.
DNA Binding Profiles
Not applicable - DMD is not a transcription factor.
Section 10: Drug & Pharmacology Data
PharmGKB
| Attribute | Value |
|---|
| PharmGKB ID | PA27378 |
| VIP Gene | Yes |
| CPIC Guideline | No |
| Chromosome | chrX |
ChEMBL Target
| Target ID | Name | Type |
|---|
| CHEMBL5498504 | Dystrophin | SINGLE PROTEIN |
Clinical Trials for Duchenne Muscular Dystrophy (Total: 100+)
Phase 4 Trials
| Trial ID | Title | Status |
|---|
| NCT04687020 | Long-term Use of Viltolarsen in Boys With DMD | ACTIVE_NOT_RECRUITING |
| NCT06713135 | Safety and Effectiveness of Long-term Treatment With Vamorolone | ACTIVE_NOT_RECRUITING |
| NCT05412394 | Once Weekly Infant Corticosteroid Trial for DMD | RECRUITING |
| NCT00606775 | Preventive Efficacy of Carvedilol on Cardiac Dysfunction | UNKNOWN |
Phase 3 Trials (Selected - Total: 50+)
| Trial ID | Intervention | Status | Phase |
|---|
| NCT05096221 | Delandistrogene Moxeparvovec (SRP-9001) | COMPLETED | Phase 3 |
| NCT04281485 | PF-06939926 (Gene therapy) | ACTIVE_NOT_RECRUITING | Phase 3 |
| NCT05693142 | RGX-202 Gene Therapy | RECRUITING | Phase 3 |
| NCT07160634 | SGT-003 Gene Therapy | RECRUITING | Phase 3 |
| NCT04060199 | Viltolarsen (RACER53) | COMPLETED | Phase 3 |
| NCT02500381 | Casimersen & Golodirsen | COMPLETED | Phase 3 |
| NCT02255552 | Eteplirsen | COMPLETED | Phase 3 |
| NCT01826487 | Ataluren | COMPLETED | Phase 3 |
| NCT02851797 | Givinostat | COMPLETED | Phase 3 |
| NCT05933057 | Givinostat (Non-ambulant) | RECRUITING | Phase 3 |
| NCT05126758 | Deramiocel (CAP-1002) | ACTIVE_NOT_RECRUITING | Phase 3 |
| NCT03703882 | Edasalonexent | COMPLETED | Phase 3 |
| NCT05066633 | Metoprolol (add-on treatment) | RECRUITING | Phase 3 |
Approved Therapies (FDA)
| Drug | Mechanism | Approval Year |
|---|
| Deflazacort (Emflaza) | Corticosteroid | 2017 |
| Eteplirsen (Exondys 51) | Exon 51 skipping | 2016 |
| Golodirsen (Vyondys 53) | Exon 53 skipping | 2019 |
| Viltolarsen (Viltepso) | Exon 53 skipping | 2020 |
| Casimersen (Amondys 45) | Exon 45 skipping | 2021 |
| Delandistrogene moxeparvovec (Elevidys) | Gene therapy | 2023 |
| Vamorolone (Agamree) | Corticosteroid | 2023 |
| Givinostat (Duvyzat) | HDAC inhibitor | 2024 |
Section 11: Expression Profiles
Bgee Expression Summary
| Attribute | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 295 |
| Total Absent Calls | 6 |
| Max Expression Score | 98.90 |
| Average Expression Score | 83.39 |
TOP 30 Tissues by Expression Score
| Tissue/Cell Type (UBERON/CL ID) | Expression | Score | Quality |
|---|
| Trigeminal ganglion (UBERON:0001675) | present | 98.90 | gold |
| Skeletal muscle tissue of rectus abdominis (UBERON:0004511) | present | 98.70 | gold |
| Dorsal root ganglion (UBERON:0000044) | present | 98.12 | gold |
| Seminal vesicle (UBERON:0000998) | present | 97.61 | gold |
| Sural nerve (UBERON:0015488) | present | 97.47 | gold |
| Biceps brachii (UBERON:0001507) | present | 97.46 | gold |
| Vastus lateralis (UBERON:0001379) | present | 97.34 | gold |
| Skeletal muscle tissue of biceps brachii (UBERON:0004502) | present | 97.29 | gold |
| Blood vessel layer (UBERON:0004797) | present | 97.19 | gold |
| Quadriceps femoris (UBERON:0001377) | present | 96.94 | gold |
| Endothelial cell (CL:0000115) | present | 96.73 | gold |
| Saphenous vein (UBERON:0007318) | present | 96.67 | gold |
| Body of tongue (UBERON:0011876) | present | 96.58 | gold |
| Cardiac muscle of right atrium (UBERON:0003379) | present | 96.49 | gold |
| Left ventricle myocardium (UBERON:0006566) | present | 96.48 | gold |
| Skeletal muscle tissue (UBERON:0001134) | present | 96.45 | gold |
| Cauda epididymis (UBERON:0004360) | present | 96.42 | gold |
| Myocardium (UBERON:0002349) | present | 96.28 | gold |
| Tibial nerve (UBERON:0001323) | present | 96.25 | gold |
| Tibialis anterior (UBERON:0001385) | present | 96.21 | gold |
| Heart right ventricle (UBERON:0002080) | present | 96.17 | gold |
| Colonic epithelium (UBERON:0000397) | present | 95.89 | gold |
| Vena cava (UBERON:0004087) | present | 95.86 | gold |
| Muscle tissue (UBERON:0002385) | present | 95.68 | gold |
| Hindlimb stylopod muscle (UBERON:0004252) | present | 95.51 | gold |
| Skeletal muscle organ (UBERON:0014892) | present | 95.39 | gold |
| Muscle organ (UBERON:0001630) | present | 95.38 | gold |
| Secondary oocyte (CL:0000655) | present | 95.31 | gold |
| Deltoid (UBERON:0001476) | present | 95.20 | gold |
| Choroid plexus epithelium (UBERON:0003911) | present | 95.11 | gold |
Expression Pattern Summary
- Highest expression: Skeletal muscle, cardiac muscle, smooth muscle, peripheral nerves
- Pattern: Tissue-enriched in muscle tissues (both skeletal and cardiac)
- Isoforms: Multiple tissue-specific promoters drive different isoforms (Dp427, Dp260, Dp140, Dp116, Dp71)
Single-Cell Expression Data (Total: 11 datasets)
| Experiment ID | Description | Species | Cell Count |
|---|
| E-ANND-2 | GTEx: snRNAseq atlas | Homo sapiens | 209,126 |
| E-MTAB-11268 | Atlas of the human hypertrophied heart | Homo sapiens | 64,898 |
| E-HCAD-31 | Pancreatic islet cells (healthy and T2D) | Homo sapiens | 38,217 |
| E-MTAB-7316 | Adult human neural retina | Homo sapiens | 25,143 |
| E-GEOD-137537 | Human Retina (Age-Related Macular Degeneration) | Homo sapiens | 12,881 |
| E-MTAB-6678 | Human first trimester fetal-maternal interface | Homo sapiens | 7,598 |
| E-MTAB-7052 | Human dermal fibroblasts | Homo sapiens | 1,920 |
| E-GEOD-130473 | Human fetal liver | Homo sapiens | 1,475 |
| E-ENAD-20 | Patient-derived xenograft model | Homo sapiens | 674 |
| E-MTAB-7303 | iPSC-dopamine neurons (Parkinson) | Homo sapiens | 123 |
Section 12: Disease Associations
Mendelian Disease Links (GenCC - Definitive/Strong)
| Disease | OMIM/MONDO | Classification | MOI | Submitter |
|---|
| Duchenne muscular dystrophy | OMIM:310200 | Definitive | X-linked | Multiple |
| Becker muscular dystrophy | OMIM:300376 | Definitive | X-linked | Ambry Genetics |
| Dilated cardiomyopathy 3B | OMIM:302045 | Definitive | X-linked | Ambry Genetics |
| Duchenne and Becker muscular dystrophy | MONDO:0016899 | Definitive | X-linked | Myriad |
Orphanet Disease Associations
| ORPHA ID | Disease Name | Type | Gene Count |
|---|
| 98896 | Duchenne muscular dystrophy | Disease | 2 |
| 98895 | Becker muscular dystrophy | Disease | 1 |
| 206546 | Symptomatic form of DMD/BMD in female carriers | Disease | 1 |
| 154 | Familial isolated dilated cardiomyopathy | Disease | 53 |
| 777 | X-linked non-syndromic intellectual disability | Subtype | 30 |
HPO Phenotype Associations (Total: 80)
TOP 50 Phenotypes
| HPO ID | Phenotype |
|---|
| HP:0003560 | Muscular dystrophy |
| HP:0003236 | Elevated circulating creatine kinase concentration |
| HP:0003707 | Calf muscle pseudohypertrophy |
| HP:0003701 | Proximal muscle weakness |
| HP:0003323 | Progressive muscle weakness |
| HP:0001644 | Dilated cardiomyopathy |
| HP:0001638 | Cardiomyopathy |
| HP:0002505 | Loss of ambulation |
| HP:0002878 | Respiratory failure |
| HP:0002747 | Respiratory insufficiency due to muscle weakness |
| HP:0003391 | Gowers sign |
| HP:0001252 | Hypotonia |
| HP:0001270 | Motor delay |
| HP:0001263 | Global developmental delay |
| HP:0001324 | Muscle weakness |
| HP:0002650 | Scoliosis |
| HP:0001371 | Flexion contracture |
| HP:0001771 | Achilles tendon contracture |
| HP:0003551 | Difficulty climbing stairs |
| HP:0002515 | Waddling gait |
| HP:0003546 | Exercise intolerance |
| HP:0030097 | Absent muscle dystrophin expression |
| HP:0003198 | Myopathy |
| HP:0003202 | Skeletal muscle atrophy |
| HP:0011675 | Arrhythmia |
| HP:0001635 | Congestive heart failure |
| HP:0025169 | Left ventricular systolic dysfunction |
| HP:0001712 | Left ventricular hypertrophy |
| HP:0002093 | Respiratory insufficiency |
| HP:0002091 | Restrictive ventilatory defect |
| HP:0001256 | Mild intellectual disability |
| HP:0100543 | Cognitive impairment |
| HP:0001328 | Specific learning disability |
| HP:0001419 | X-linked recessive inheritance |
| HP:0001417 | X-linked inheritance |
| HP:0003621 | Juvenile onset |
| HP:0011463 | Childhood onset |
| HP:0008981 | Calf muscle hypertrophy |
| HP:0003731 | Quadriceps muscle weakness |
| HP:0003326 | Myalgia |
| HP:0003710 | Exercise-induced muscle cramps |
| HP:0002913 | Myoglobinuria |
| HP:0002380 | Fasciculations |
| HP:0003457 | EMG abnormality |
| HP:0003115 | Abnormal EKG |
| HP:0002870 | Obstructive sleep apnea |
| HP:0012378 | Fatigue |
| HP:0002527 | Falls |
| HP:0030051 | Tip-toe gait |
| HP:0001288 | Gait disturbance |
GWAS Associations (Total: 11)
| Study ID | Trait | P-value |
|---|
| GCST003124_19 | Mild influenza (H1N1) infection | 5.0e-14 |
| GCST003125_11 | Influenza A (H1N1) infection | 4.0e-11 |
| GCST012304_6 | Major depressive disorder | 1.0e-09 |
| GCST004904_60 | Body mass index | 1.0e-08 |
| GCST004034_1 | Temporomandibular joint disorder | 4.0e-08 |
| GCST009139_1 | Ankle-brachial index | 7.0e-08 |
| GCST001308_20 | Response to anti-depressant treatment in MDD | 2.0e-06 |
| GCST002202_3 | Anxiety in major depressive disorder | 4.0e-06 |
| GCST004862_35 | Itch intensity from mosquito bite | 5.0e-06 |
| GCST008151_58 | Waist circumference | 4.0e-06 |
| GCST008160_82 | Waist circumference | 4.0e-06 |
Summary Statistics
| Category | Count |
|---|
| Ensembl Transcripts | 91 |
| RefSeq mRNA (Human) | 17 |
| CCDS IDs | 11 |
| Exons (Canonical) | 79 |
| Protein Length | 3,685 aa |
| InterPro Domains | 14 |
| PDB Structures | 5 |
| Orthologs | 3 (+ 36 paralogs) |
| ClinVar Variants | 11,261 |
| SpliceAI Predictions | 7,041 |
| AlphaMissense Predictions | 24,447 |
| Reactome Pathways | 3 |
| GO Terms | 51 |
| STRING Interactions | 2,170+ |
| HPO Phenotypes | 80 |
| Clinical Trials | 100+ |
| Expression Tissues | 295 |
This reference document provides a comprehensive cross-database mapping for human DMD gene. Data sourced from: HGNC, Ensembl, NCBI, UniProt, PDB, ClinVar, SpliceAI, AlphaMissense, Reactome, Gene
Ontology, STRING, BioGRID, IntAct, Bgee, Orphanet, GenCC, HPO, GWAS Catalog, PharmGKB, and ChEMBL via biobtree.